Skip to main content
Fig. 1 | Journal for ImmunoTherapy of Cancer

Fig. 1

From: PD-L1 expression is a predictive biomarker for CIK cell-based immunotherapy in postoperative patients with breast cancer

Fig. 1

The phenotype of CIK cells in breast cancer patients before and after the expansion. a The percentage of CD3+CD4+ T cells, CD3+CD8+ T cells, CD3+CD56+ NKT cells, CD3CD56+ NK cells, and CD4+CD25+ regulatory T cells of CIK cells before and after the expansion. b The percentage of CD4+ central memory T cells (TCM), CD4+ effector memory T cells (TEM), CD8+ TCM, and CD8+ TEM of CIK cells before and after the expansion. * p < 0.05

Back to article page